Effects of Transcranial Direct Current Stimulation (tDCS) on Persistent Auditory Verbal Hallucinations in Schizophrenia
Auditory Hallucination, Verbal
About this trial
This is an interventional treatment trial for Auditory Hallucination, Verbal focused on measuring Schizophrenia, Transcranial direct current stimulation (tDCS), Schizoaffective disorder, EEG, Brain imaging, Cognition
Eligibility Criteria
Patients - Inclusion Criteria:
- Primary diagnosis of schizophrenia or schizoaffective disorder
- Clinically stable (discretion of psychiatrist)
- Consistent history of AVHs over the course of illness
- >3 AVHs per week
- Positive and Negative Syndrome Scale (PANSS) score of >3
- Primary medications limited to one of the atypical antipsychotics (medications stabilized for 4 weeks prior to enrollment)
Patients - Exclusion Criteria:
- Experiencing an acute psychotic episode
- Current drug/alcohol dependence
- Significant medical illness & mental retardation/learning disability
- Extra-pyramidal symptoms resulting in disordered movement
- Abnormal audiometric assessment (thresholds for pure tones >25 dB)
- History of significant neurological issues & head injuries/concussions resulting in loss of consciousness for >5 minutes
Healthy Controls - Inclusion Criteria:
- In good physical health
- No history of serious mental health issues
Healthy Controls - Exclusion Criteria:
- Personal history of psychiatric disorder
- Family history of schizophrenia in first degree relatives & history of mental health issues in first degree relatives that required extensive treatment or hospitalization
- Current/history of substance abuse
- Significant medical illness
- Extra-pyramidal symptoms resulting in movement disorder
- Abnormal audiometric assessment (thresholds for pure tones >25 dB)
- Significant neurological issues & head injuries/concussions resulting in loss of consciousness for >5 minutes
Sites / Locations
- Royal Ottawa Mental Health CentreRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Sham Comparator
Other
No Intervention
Active tDCS
Sham tDCS
Open-label Active tDCS
Healthy Control
Administration of a 2 milliamp (mA) current delivered via two scalp electrodes for 20 minutes (ramp-in + ramp-out periods, 30s total) 2 times per day for 5 consecutive days, >3 hour interval between sessions, for a total of 10 tDCS sessions. tDCS will be administered with a constant current regulator (NeuroConn DC-Stimulator Plus®, Germany) using 2 saline-soaked sponge electrodes applied over the scalp. Using the 10-20 international EEG system for tDCS electrode placement, the anode will be positioned midway between F3 and Fp1 (left DLPFC) and the cathode midway between T3 and P3 (left TPJ).
Administration of 2mA tDCS for 30 seconds followed by 19.5 minutes of no current via two scalp electrodes for 20 min (2X/day for 5 consecutive days) with >3 hours interval between sessions, for a total of 10 tDCS sessions.
Subjects who have received sham tDCS will be given the option to subsequently receive 10 sessions of open-label active tDCS (2X/day for 5 consecutive days) with >3 hours interval between sessions, for a total of 10 tDCS sessions.
Healthy volunteers will complete the same questionnaires, EEG recording procedures, and neuroimaging scans as the schizophrenia patient group, but will not undergo tDCS.